Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Positive association of Angiotensin II Receptor Blockers, not Angiotensin-Converting Enzyme Inhibitors, with an increased vulnerability to SARS-CoV-2 infection in patients hospitalized for suspected COVID-19 pneumonia

Jean-Louis Georges, Floriane Gilles, Hélène Cochet, Alisson Bertrand, Marie De Tournemire, Victorien Monguillon, Maeva Pasqualini, Alix Prevot, Guillaume Roger, Joseph Saba, Joséphine Soltani, Mehrsa Koukabi-Fradelizi, Jean-Paul Beressi, Cécile Laureana, Jean-François Prost, Bernard Livarek
doi: https://doi.org/10.1101/2020.08.30.20182451
Jean-Louis Georges
1Department of cardiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jgeorges@ch-versailles.fr
Floriane Gilles
1Department of cardiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hélène Cochet
1Department of cardiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alisson Bertrand
1Department of cardiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie De Tournemire
1Department of cardiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Victorien Monguillon
1Department of cardiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maeva Pasqualini
1Department of cardiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alix Prevot
1Department of cardiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guillaume Roger
1Department of cardiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Saba
1Department of cardiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joséphine Soltani
1Department of cardiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mehrsa Koukabi-Fradelizi
2Emergency department
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Paul Beressi
3Department of diabetology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cécile Laureana
4Department of medical information, Centre Hospitalier de Versailles, Le Chesnay, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-François Prost
1Department of cardiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernard Livarek
1Department of cardiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Angiotensin converting enzyme (ACE) type 2 is the receptor of SARS-CoV-2 for entry into lungs cells. Because ACE-2 may be modulated by ACE inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs), there is concern that patients treated with ACEIs and ARBs are at higher risk for COVID-19 infection.

Aim This study sought to analyze the association of COVID-19 with previous treatment with ACEI and ARB.

Methods We retrospectively reviewed 684 consecutive patients hospitalized for suspected COVID-19 pneumonia and tested by PCR. Patients were split into 2 groups, whether (group 1, n=484) or not (group 2, n=250) COVID-19 was confirmed. Multivariate adjusted comparisons included a propensity score analysis.

Results Age was 63.6±18.7 years, and 302(44%) were female. Hypertension was present in 42.6% and 38.4% patients of group 1 and 2, respectively (P=0.28). A treatment with ARBs (20.7% versus 12.0%, respectively, OR 1.92, 95% confidence interval [1.23-2.98], p=0.004) was more frequent in patients of group 1 than in group 2. No difference was found for treatment with ACEIs (12.7% vs 15.7%, respectively, OR 0.81 [0.52-1.26], p=0.35). Propensity score matched multivariate logistic regression confirmed a significant association between COVID-19 and a previous treatment with ARBs (adjusted OR 2.18 [1.29-3.67], p=0.004). Significant interaction between ARBs and ACEIs for the risk of COVID-19 was observed in patients aged>60, women, and hypertensive patients.

Conclusion This study suggests that ACEIs and ARBs are not similarly associated with the COVID-19. In this retrospective series, patients with COVID-19 pneumonia received more frequently a previous treatment with ARBs, than patients without COVID-19.

Competing Interest Statement

JLG has received consultant or speaker fees from AstraZeneca France, Sanofi-Aventis, Amgen, and Merck Sharpe and Dohme, which are not related to the present work. No conflicts of interest were disclosed for the other authors.

Clinical Trial

NCT04374695

Funding Statement

This study was founded by the Centre Hospitalier de Versailles, Le Chesnay, France. The authors received no specific funding for this work.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by Comite de Protection des personnes Ouest VI (CPP Ouest 6; CPP 1296 HPS3; Number 2020 A01516 33) Written consent of patients was obtained

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All relevant data are within the manuscript and its Supporting Information files

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted September 01, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Positive association of Angiotensin II Receptor Blockers, not Angiotensin-Converting Enzyme Inhibitors, with an increased vulnerability to SARS-CoV-2 infection in patients hospitalized for suspected COVID-19 pneumonia
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Positive association of Angiotensin II Receptor Blockers, not Angiotensin-Converting Enzyme Inhibitors, with an increased vulnerability to SARS-CoV-2 infection in patients hospitalized for suspected COVID-19 pneumonia
Jean-Louis Georges, Floriane Gilles, Hélène Cochet, Alisson Bertrand, Marie De Tournemire, Victorien Monguillon, Maeva Pasqualini, Alix Prevot, Guillaume Roger, Joseph Saba, Joséphine Soltani, Mehrsa Koukabi-Fradelizi, Jean-Paul Beressi, Cécile Laureana, Jean-François Prost, Bernard Livarek
medRxiv 2020.08.30.20182451; doi: https://doi.org/10.1101/2020.08.30.20182451
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Positive association of Angiotensin II Receptor Blockers, not Angiotensin-Converting Enzyme Inhibitors, with an increased vulnerability to SARS-CoV-2 infection in patients hospitalized for suspected COVID-19 pneumonia
Jean-Louis Georges, Floriane Gilles, Hélène Cochet, Alisson Bertrand, Marie De Tournemire, Victorien Monguillon, Maeva Pasqualini, Alix Prevot, Guillaume Roger, Joseph Saba, Joséphine Soltani, Mehrsa Koukabi-Fradelizi, Jean-Paul Beressi, Cécile Laureana, Jean-François Prost, Bernard Livarek
medRxiv 2020.08.30.20182451; doi: https://doi.org/10.1101/2020.08.30.20182451

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Cardiovascular Medicine
Subject Areas
All Articles
  • Addiction Medicine (215)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1093)
  • Dentistry and Oral Medicine (195)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (499)
  • Epidemiology (9759)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2304)
  • Geriatric Medicine (222)
  • Health Economics (462)
  • Health Informatics (1554)
  • Health Policy (733)
  • Health Systems and Quality Improvement (602)
  • Hematology (236)
  • HIV/AIDS (501)
  • Infectious Diseases (except HIV/AIDS) (11635)
  • Intensive Care and Critical Care Medicine (616)
  • Medical Education (236)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2140)
  • Nursing (134)
  • Nutrition (336)
  • Obstetrics and Gynecology (426)
  • Occupational and Environmental Health (517)
  • Oncology (1172)
  • Ophthalmology (363)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (145)
  • Palliative Medicine (50)
  • Pathology (309)
  • Pediatrics (694)
  • Pharmacology and Therapeutics (298)
  • Primary Care Research (265)
  • Psychiatry and Clinical Psychology (2173)
  • Public and Global Health (4649)
  • Radiology and Imaging (775)
  • Rehabilitation Medicine and Physical Therapy (455)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (210)
  • Surgery (250)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)